Varicella Zoster Infection Treatment Market

The varicella zoster infection treatment market is projected to grow from USD 1.8 billion in 2025 to USD 2.7 billion by 2035, at a CAGR of 4.1%. Acyclovir will dominate with a 46.7% market share, while oral will lead the route of administration segment with a 58.1% share.